The extraction recovery is used to evaluate the extraction ability of the sample processing from the biosamples. The validation focuses on whether the analyte could be completely extracted.

In the study of pharmacokinetics and bioavailability, LLOQ should be able to determine the drug concentration in biosamples at 3-5 elimination half-lives after dosing or within the range of 1/5 to 1/2 of the Cmax.